← Eichor
Condition: Inflammatory Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Inflammatory

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PK/PD of Ceftazidime Avitbatan Sodium in Children With Severe Infection
Phase N/A · 1 location(s) · Children's Hospital of Fudan University · NCT04961580Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise
NA · 1 location(s) · University of Southern California · NCT05934708The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid
NA · 3 location(s) · The Bionics Institute of Australia · NCT07017686Cellvizio to Evaluate Margins in Crohn's Ileal Disease
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05805020A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012Erector Spinae Plane Block Improves Organ Dysfunction in Septic Patients With Acute Gastrointestinal Injury
NA · 1 location(s) · Jing Cai, MD · NCT05623722A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas
Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06490757Montreal Immune-Related Adverse Events (MIRAE) Study
Phase N/A · 1 location(s) · Sir Mortimer B. Davis - Jewish General Hospital · NCT05139706Non-steroidal Anti-inflammatory Drugs in Pleurodesis
Phase 2 · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06731647Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Phase 1/Phase 2 · 3 location(s) · St. Jude Children's Research Hospital · NCT04195347Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease
NA · 1 location(s) · Ruijin Hospital · NCT05887674Linezolid Plus Standard of Care
NA · 12 location(s) · University Hospital, Basel, Switzerland · NCT06958835Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins
NA · 1 location(s) · Cosmetique Active International · NCT06253468Comparison of Diagnostic Methods in Patients Operated for Suspected Appendicitis
Phase N/A · 1 location(s) · Sanliurfa Education and Research Hospital · NCT07496723Study of XmAb412 in Healthy Participants
Phase 1 · 2 location(s) · Xencor, Inc. · NCT07713485A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
Phase 1 · 1 location(s) · Xencor, Inc. · NCT07284797Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowe
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07533890Evaluation of Efficacy and Safety of Rituximab in Patients With Progressive Interstitial Lung Disease (ILD) With Inflamm
Phase 3 · 1 location(s) · University Hospital, Tours · NCT05596786Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study
Phase N/A · 1 location(s) · Seoul National University Bundang Hospital · NCT07539883Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopea
Phase N/A · 1 location(s) · Imelda GI Clinical Research Center · NCT07621783Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Ri
Phase N/A · 2 location(s) · Angelina Passaro · NCT07602023Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Phase N/A · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT01143480Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed
Phase 2 · 1 location(s) · Naresh Bumma · NCT07657312Effectiveness of Anti-Inflammatory Drugs for Preventing Pain Versus Treating Pain During Medical Abortion From 13 to 22
NA · 1 location(s) · Le Thi Kieu Trang · NCT06696573TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)
Phase N/A · 18 location(s) · Groupe d'Etude Therapeutique des Affections Inflammatoires D · NCT05903066Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic Intestinal Crohn's Disease
Phase N/A · 1 location(s) · University of Edinburgh · NCT07152431Effect of Empagliflozin on Inflammation
Phase 4 · 1 location(s) · Hotel Dieu de France Hospital · NCT07292909Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study
NA · 6 location(s) · University of Glasgow · NCT07522528Fecal Microbiota Transplant for Patients With Chronic Pouchitis
EARLY_Phase 1 · 1 location(s) · Maia Kayal · NCT05829109Specifying the Anti-inflammatory Effects of Ziltivekimab
Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06263244
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.